Cargando…
Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839329/ https://www.ncbi.nlm.nih.gov/pubmed/31736589 http://dx.doi.org/10.4103/aian.AIAN_536_18 |
| _version_ | 1783467398082330624 |
|---|---|
| author | Maramattom, Boby V. Thomas, Joe |
| author_facet | Maramattom, Boby V. Thomas, Joe |
| author_sort | Maramattom, Boby V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6839329 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68393292019-11-15 Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus Maramattom, Boby V. Thomas, Joe Ann Indian Acad Neurol Letters to the Editor Wolters Kluwer - Medknow 2019 2019-10-25 /pmc/articles/PMC6839329/ /pubmed/31736589 http://dx.doi.org/10.4103/aian.AIAN_536_18 Text en Copyright: © 2006 - 2019 Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letters to the Editor Maramattom, Boby V. Thomas, Joe Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus |
| title | Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus |
| title_full | Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus |
| title_fullStr | Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus |
| title_full_unstemmed | Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus |
| title_short | Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus |
| title_sort | reversal of anticoagulation effect of dabigatran with idarucizumab, for thrombolysis in acute ischemic stroke: inimicus inimico amicus |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839329/ https://www.ncbi.nlm.nih.gov/pubmed/31736589 http://dx.doi.org/10.4103/aian.AIAN_536_18 |
| work_keys_str_mv | AT maramattombobyv reversalofanticoagulationeffectofdabigatranwithidarucizumabforthrombolysisinacuteischemicstrokeinimicusinimicoamicus AT thomasjoe reversalofanticoagulationeffectofdabigatranwithidarucizumabforthrombolysisinacuteischemicstrokeinimicusinimicoamicus |